These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9621756)

  • 1. [Peroral anticoagulant therapy--are the TT-values reliable?].
    Eilertsen H; Asprang AF; Ulveland K; Nerdrum HJ
    Tidsskr Nor Laegeforen; 1998 Apr; 118(11):1690-2. PubMed ID: 9621756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of evacuated tubes for blood collection in oral anticoagulant control.
    van den Besselaar AM; van Halem-Visser LP; Loeliger EA
    Thromb Haemost; 1983 Oct; 50(3):676-7. PubMed ID: 6648890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The perioperative management of warfarin therapy.
    Ansell JE
    Arch Intern Med; 2003 Apr; 163(8):881-3. PubMed ID: 12719195
    [No Abstract]   [Full Text] [Related]  

  • 5. [Better quality of thrombotest in family practice. Results from the NOKLUS survey 1993-97].
    Gidske G; Christensen NG; Jevnaker M; Skurtveit KJ; Thue G; Klovning A; Sandberg S
    Tidsskr Nor Laegeforen; 1998 Mar; 118(8):1196-200. PubMed ID: 9567696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy. V. Oral anticoagulant therapy.
    Holcenberg JS; Veltkamp JJ
    Northwest Med; 1970 Jun; 69(6):421-4. PubMed ID: 4193910
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhagic femoral neuropathy: report of a case due to anticoagulant.
    Gilbert GJ; Laughlin R
    Dis Nerv Syst; 1977 May; 38(5):365. PubMed ID: 192522
    [No Abstract]   [Full Text] [Related]  

  • 11. Home prothrombin time monitoring: a literature analysis.
    Yang DT; Robetorye RS; Rodgers GM
    Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing risks for patients receiving warfarin.
    Bush J
    Fam Pract Manag; 2002; 9(7):35-8. PubMed ID: 12221762
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inter-institute variations in International Normalized Ratio and thrombotest].
    Nozawa T; Hayashi S; Naiki S; Niiya K; Asanoi H; Inoue H
    J Cardiol; 1998 Aug; 32(2):89-94. PubMed ID: 9752617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of prothrombin time and thrombotest and hepaplastin test for the control of oral anticoagulant therapy].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Feb; 31(2):210-4. PubMed ID: 6855001
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical liability risk avoidance: a case for adopting the International Normalized Ratio (INR) system.
    Kline SS; Atkins MO
    Am J Manag Care; 1997 Jan; 3(1):59-63. PubMed ID: 10169250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I have an artificial heart valve and am on warfarin for life. I would like to be able to test my own clotting at home. I have heard that there are test devices for this, as there are for diabetics. Why don't more warfarin patients know about them?
    Health News; 2006 Apr; 12(4):16. PubMed ID: 16583499
    [No Abstract]   [Full Text] [Related]  

  • 17. [Better AVK treatment with self monitoring. Dosage can be regulated in time].
    Stigendal L; André U; Christenson B
    Lakartidningen; 1999 May; 96(20):2482, 2485-7. PubMed ID: 10380494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Auricular already exists!].
    Själander A
    Lakartidningen; 2008 May 21-27; 105(21):1594; author reply 1594. PubMed ID: 18575001
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.